Back to Screener

Healthcare

Abiomed, Inc.(ABMD)

Live Price

Offline

$381.02

+0.00% today

1Y Change

—

Window

No data

Market Cap
$17.18B
Revenue Growth
+21.7%
EPS Growth
-40.0%
Dividend Yield
0.0%
No coverage

Historical coverage is still loading

We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.

No price data

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Abiomed, Inc. (ABMD) is a Healthcare stock with a market cap of $17.18B and listed on NASDAQ. The stock last traded around $381.02. Baseline metrics include revenue growth of +21.7%, EPS growth of -40.0%, a dividend yield of 0.0%. What stands out right now is revenue +21.7%, EPS -40.0%, free cash flow +12.9% with operating margin 36.1% and ROIC 17.4%. Valuation already assumes a fairly strong business story at P/E 126.8 and price/sales 16.7. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines ABMD price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

ABMD

—

Normalized return

SPY

—

S&P 500

Excess Return

—

Relative to SPY

ABMD Max Drawdown

—

Trailing 1Y

SPY Max Drawdown

—

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for ABMD and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

📅 Last reportedNov 3, 2023
PeriodB/MEPSEPS ΔRevenueRev ΔReport
—
Nov 3, 23
—
Est —
—
—
Est 295370.0B
—
Nov 3
—
Aug 2, 23
—
Est —
—
—
Est 295370.0B
—
Aug 2
—
Apr 26, 23
—
Est —
—
—
Est 295370.0B
—
Apr 26
—
Feb 2, 23
—
Est 1.03
—
—
Est 288720.0B
—
Feb 2
—
Nov 1, 22
✓
1.30
Est 1.04
+25.0%
265921.0B
Est —
—
Nov 1
—
Aug 4, 22
✓
1.25
Est 1.06
+17.9%
277149.0B
Est —
—
Aug 4
—
Apr 28, 22
✓
1.16
Est 1.09
+6.4%
269850.0B
Est 252520.2B
+6.9%
Apr 28
—
Feb 3, 22
✓
1.13
Est 0.95
+18.9%
261176.0B
Est 266770.0B
-2.1%
Feb 3
—
Oct 28, 21
✓
1.03
Est 0.97
+6.2%
248142.0B
Est 251600.0B
-1.4%
Oct 28
—
Aug 4, 21
✓
1.41
Est 1.05
+34.3%
252585.0B
Est 252585.0B
0.0%
Aug 4
—
Apr 29, 21
✓
1.24
Est 1.10
+12.7%
241245.0B
Est 230380.0B
+4.7%
Apr 29
—
Jan 28, 21
✓
1.35
Est 1.13
+19.5%
231663.0B
Est 225590.0B
+2.7%
Jan 28
—
Oct 29, 20
✓
1.36
Est 0.92
+47.8%
209764.0B
Est 141899.2B
+47.8%
Oct 29
—
Aug 6, 20
✓
0.98
Est 0.29
+237.9%
164850.0B
Est 48782.1B
+237.9%
Aug 6
—
Apr 30, 20
✗
0.70
Est 0.94
-25.5%
206658.0B
Est 277512.2B
-25.5%
Apr 30
—
Feb 6, 20
✓
1.51
Est 1.09
+38.5%
221584.0B
Est 159951.4B
+38.5%
Feb 6
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener